Founded in 2006, Glytec™ is a rapidly growing clinical information technology company solely dedicated to the mission of improving insulin management and glycemic control. The eGlycemic Management System™ (eGMS™) enables hospitals, healthcare systems, medical homes and population health managers to significantly reduce the frequency, risks and costs of hyperglycemia and hypoglycemia and offer superior care to their diabetes patients. Improvements in glycemic control are proven to reduce rates of infection, length-of-stay, readmissions and point-of-care testing.
With the considerable input of clients, thought leaders and the general healthcare community, Glytec’s solution has evolved dramatically over its eight year history; from the very first of its kind, computerized IV insulin dosing tool to the very first and only comprehensive, integrated glycemic management and surveillance system. The eGMS includes the only suite of FDA-cleared, computerized, predictive dosing algorithms for IV, subcutaneous and pediatric dosing: Glucommander IV™ (FDA clearance 2006), Glucommander SubQ™ (FDA clearance 2010) and Glucommander Pediatrics™ (FDA clearance 2012).
The breadth and depth of the Glucommander Suite™ allows health systems to standardize its approach across all areas of the organization and across the care continuum and reduce clinical variability. The cloud-based system seamlessly integrates with leading electronic medical records (EMR), improving access, workflow, efficiency and care team coordination. Also included in the eGMS are advanced clinical and business intelligence analytics and real-time surveillance capabilities. The system not only provides front line clinicians greater safety, efficacy and assurance in administering insulin therapy (one of the most prevalent sources of adverse drug events and thus a common source of anxiety for most nurses) but also allows clinicians to identify patients that are in need of therapy sooner.
Website Link:
Member Category: